⚠ For in-vitro research purposes only. Strictly not for human or veterinary use.
Australian Peptide Lab kangaroo logo
Glossary

What is Peptide solubility?

Also called: Solubility, Aqueous solubility, Intrinsic solubility

The highest concentration at which a peptide stays in true solution under stated conditions of solvent, pH, ionic strength and temperature.

By the APL Research Team Β· Updated

Peptide solubility is the maximum concentration a peptide reaches in true solution before excess material stays undissolved or separates out. It is always conditional: "soluble in water" describes one concentration, in one solvent, at one pH and temperature, for one salt form. Change any of those and the ceiling moves.

Four things that get called "solubility"

ConceptWhat it describesTypical bench symptom
Equilibrium solubilityThe true ceiling at equilibriumMaterial left over however long it sits
Dissolution rateHow quickly the dry solid goes inFlakes that clear after several minutes of gentle swirling
Apparent (kinetic) solubilityA solution pushed above its ceiling, for example by diluting a concentrated stock into bufferClear at first, hazy an hour later
Solution stabilityWhether dissolved peptide stays monomericPrecipitate or gel forming over days; see aggregation

Treating a slow dissolution as insolubility, or a kinetic solution as a stable one, accounts for many failed stocks.

What sets the ceiling

The sequence fixes an intrinsic solubility. Sequence-based predictors now estimate it computationally; CamSol-PTM, for instance, predicts aqueous solubility at room temperature for peptides containing modified or non-natural residues, and its predictions were checked against measured values for 37 peptide variants [1]. Conditions then shift that baseline. In engineered variants of ribonuclease Sa, the pH of minimum solubility moved with the isoelectric point [2]. Yet in salting-out experiments with five proteins, neither aggregate nor crystal solubility had a minimum at the pI [3]. Distance from the pI is a strong first guide rather than a law, and added salt can change the answer.

Worked example: a mg/mL ceiling in molar terms

Solubility is usually quoted in mg/mL, but experiments are designed in molar units. The same mass ceiling means very different molar stocks:

PeptideMolecular weight (g/mol)1 mg/mL equalsMass needed for a 10 mM stock
Ipamorelin711.91.40 mM7.1 mg/mL
Semax813.91.23 mM8.1 mg/mL
BPC-1571,419.50.70 mM14.2 mg/mL
Tesamorelin5,1360.19 mM51.4 mg/mL

The 10 mM stock convention borrowed from small-molecule screening becomes a demand for more than 50 mg/mL with a 44-residue peptide, a concentration at which aggregation is far more likely. A 1 mM stock, 5.1 mg/mL for tesamorelin, is a more modest starting point. The molarity calculator converts in either direction, and the molarity calculations guide adds the net peptide content correction.

Common misunderstandings

  • "Not dissolved in 30 seconds means insoluble." Lyophilised cakes can wet slowly. Time and gentle swirling come before any change of solvent, as the reconstitution guide describes.
  • "Soluble in water means soluble in my buffer." Salt and pH change protein–protein interactions and phase behaviour [3]; a stock made in dilute acid can drop out when diluted into neutral buffer if the final pH lands near its pI.
  • "Low recovery at low concentration means poor solubility." At microgram-per-mL levels, binding to tube and vial surfaces causes losses that differ by peptide and by surface [4]. That is adsorption, and the fix is different labware or a carrier protein, not a stronger solvent.

When a sequence does resist water, the solubility troubleshooting guide sets out an escalation from pH adjustment to co-solvents, with the chemical cost of each step.

References

  1. 1.Oeller M, Kang RJD, Bolt HL, et al. Sequence-based prediction of the intrinsic solubility of peptides containing non-natural amino acids. Nat Commun. 2023. PubMed 37978172
  2. 2.Shaw KL, Grimsley GR, Yakovlev GI, et al. The effect of net charge on the solubility, activity, and stability of ribonuclease Sa. Protein Sci. 2001. PubMed 11369859
  3. 3.Dumetz AC, Chockla AM, Kaler EW, et al. Effects of pH on protein-protein interactions and implications for protein phase behavior. Biochim Biophys Acta. 2008. PubMed 18258214
  4. 4.Goebel-Stengel M, Stengel A, TachΓ© Y, et al. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011. PubMed 21315060

Learn more in the research library

Australian owned & operatedHPLC + mass-spec tested batchesDispatched express from Australian stockSecure Australian card payments